title: Pathophysiology of the rhesus macaque model for inhalational brucellosis.
abstract: The objective of this study was to characterize the rhesus macaque (RM) as a model for inhalational brucellosis in support of the U.S. Food and Drug Administration's (FDA) Animal Rule. The pathophysiology of chronic Brucella melitensis aerosol infection was monitored in two phases that each occurred over an 8-week time period; dose escalation (8 RMs; targeted doses of 5.0E+03, 5.0E+04, or 5.0E+05 CFU/animal or the unchallenged control) and natural history (12 RMs; targeted dose of 2.50E+05 CFU/animal or the unchallenged control). RMs given an aerosol challenge with B. melitensis developed undulating fevers (6/6 phase I; 8/9 phase II), positive enriched blood cultures (5/10; phase II), and bacterial burdens in tissues starting 14 to 21 days postchallenge (6/6 phase I; 10/10 phase II). In addition, 80% (8/10; phase II) of infected RMs seroconverted 14 to 21 days postchallenge. RMs developed elevations in certain liver enzymes and had an increased inflammatory response by 3 weeks postchallenge as shown by increases in C-reactive protein (6/8) and neopterin (4/8), which correlated with the onset of a fever. As early as 14 days postchallenge, positive liver biopsy specimens were detected (2/8), and ultrasound imaging showed the development of splenomegaly. Finally, histopathologic examination found lesions attributed to Brucella infection in the liver, kidney, lung, and/or spleen of all animals. The disease progression observed with the RMs in this study is analogous to human brucellosis pathophysiology. Thus, the results from this study support the use of the RM as an animal model for inhalational brucellosis to evaluate the efficacy of novel vaccines and therapeutics against B. melitensis.
authors: Battelle, Columbus, OH, USA. henningl@battelle.org
authors: Lisa N
authors: LN
authors: Henning
authors: Stephen M
authors: SM
authors: Miller
authors: Dennis H
authors: DH
authors: Pak
authors: Amber
authors: A
authors: Lindsay
authors: David A
authors: DA
authors: Fisher
authors: Roy E
authors: RE
authors: Barnewall
authors: Crystal M
authors: CM
authors: Briscoe
authors: Michael S
authors: MS
authors: Anderson
authors: Richard L
authors: RL
authors: Warren
mesh_terms: D000825:Animal Structures / Q000382:microbiology / Q000473:pathology; D000818:Animals; D058491:Bacterial Load; D017347:Brucella melitensis / Q000472:pathogenicity*; D002006:Brucellosis / Q000473:pathology* / Q000503:physiopathology*; D002097:C-Reactive Protein / Q000032:analysis; D004195:Disease Models, Animal; D004798:Enzymes / Q000097:blood; D005260:Female; D005334:Fever / Q000382:microbiology; D006651:Histocytochemistry; D019570:Inhalation Exposure; D008099:Liver / Q000201:enzymology / Q000473:pathology; D008111:Liver Function Tests; D008253:Macaca mulatta; D008297:Male; D018419:Primate Diseases / Q000473:pathology* / Q000503:physiopathology*; D013163:Splenomegaly / Q000175:diagnosis; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D004798:Enzymes; D002097:C-Reactive Protein